<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="55d5f933-42ff-4c80-a102-0ccb7f76b082"><labelDrug name="CALAN"><Normalization/></labelDrug><generic name="verapamil hydrochloride"/><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.1" text="CALAN (verapamil hydrochloride) tablet, film coated" type="negative"><entity charOffset="0:5" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.1.e.0" text="calan" type="Biomedical_Entity"><Normalization><mmtx cui="C0700935" phraseText="CALAN" preferredWord="Calan" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><entity charOffset="7:30" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.1.e.1" text="verapamil hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700468" phraseText="(verapamil hydrochloride" preferredWord="Verapamil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.1.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.1.e.1"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2" text="CALAN (verapamil HCl) is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets containing 40 mg, 80 mg, or 120 mg of verapamil hydrochloride." type="negative"><entity charOffset="7:20" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.0" text="verapamil hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0700468" phraseText="(verapamil HCl)" preferredWord="Verapamil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.1" text="calcium ion" type="Biomedical_Entity"><Normalization><mmtx cui="C0596235" phraseText="a calcium ion influx inhibitor" preferredWord="Calcium ion" semType="phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="190:223" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.2" text="120 mg verapamil hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C2740037" phraseText="120 mg of verapamil hydrochloride." preferredWord="Verapamil hydrochloride 120 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:5" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.3" text="calan" type="Biomedical_Entity"><Normalization><mmtx cui="C0700935" phraseText="CALAN" preferredWord="Calan" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><entity charOffset="81:103" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.4" text="calcium antagonist" type="Biomedical_Entity"><Normalization><mmtx cui="C0006684" phraseText="calcium ion antagonist" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="62:77" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.5" text="channel blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0870261" phraseText="(slow-channel blocker" preferredWord="channel blockers" semType="phsu"/><RxNorm RxCui="20793"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.1"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.2"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.0"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.4"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.5"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.2"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.1"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.4"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.5"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.2"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.4" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.2"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.5" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.2"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.4"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.5"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.5" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.2.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15" lineNumber="20" text="Verapamil should be avoided in patients with severe left ventricular dysfunction (eg, ejection fraction less than 30%) or moderate to severe symptoms of cardiac failure and in patients with any degree of ventricular dysfunction if they are receiving a beta-adrenergic blocker (see PRECAUTIONS, Drug interactions). " type="regular"><entity charOffset="252:275" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.0" text="beta-adrenergic blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="a beta-adrenergic blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="a beta-adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="17:27" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.1" text="be avoided" type="Caution_Interaction"/><entity charOffset="0:9" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.3" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="204:227" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.4" text="ventricular dysfunction" type="SPAN"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.1"><relations><relation type="hasContext"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.4" ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.0" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.15.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16" text="Patients with milder ventricular dysfunction should, if possible, be controlled with optimum doses of digitalis and/or diuretics before verapamil treatment. " type="negative"><entity charOffset="136:145" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="diuretics before verapamil treatment." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="102:111" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.1" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="controlled with optimum doses of digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="119:128" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics before verapamil treatment." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.0"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.0"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.16.e.2"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.30" text="Some patients with paroxysmal and/or chronic atrial fibrillation or atrial flutter and a coexisting accessory AV pathway have developed increased antegrade conduction across the accessory pathway bypassing the AV node, producing a very rapid ventricular response or ventricular fibrillation after receiving intravenous verapamil (or digitalis)." type="negative"><entity charOffset="319:328" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.30.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="receiving intravenous verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="333:342" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.30.e.1" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.30.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.30.e.1"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.40" text="In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen. " type="negative"><entity charOffset="130:139" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.40.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="therapy with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="91:102" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.40.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="intolerant to propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.40.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.40.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45" lineNumber="42" text="Concomitant administration of quinidine (see PRECAUTIONS, Drug interactions) preceded the severe hypotension in 3 of the 8 patients (2 of whom developed pulmonary edema). " type="irregular"><entity charOffset="30:39" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45.e.0" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="Concomitant administration of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="90:108" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45.e.1" text="severe hypotension" type="Specific_Interaction"/><entity charOffset="121:131" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45.e.3" text="8 patients" type="SPAN"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.40" text="In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen. "><entity charOffset="130:139" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.40.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="therapy with verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.41" text="Three patients died in pulmonary edema; "/><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.42" text="all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction. "/><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.43" text="Eight other patients had pulmonary edema and/or severe hypotension; "/><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.44" text="abnormally high (greater than 20 mm Hg) pulmonary wedge pressure and a marked left ventricular outflow obstruction were present in most of these patients. "/></relation><relation type="hasEvidence"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.45.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57" lineNumber="54" text="It has been reported that verapamil decreases neuromuscular transmission in patients with Duchenne's muscular dystrophy, prolongs recovery from the neuromuscular blocking agent vecuronium, and causes a worsening of myasthenia gravis. " type="regular"><entity charOffset="26:35" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="that verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="121:138" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.1" text="prolongs recovery" type="Increase_Interaction"/><entity charOffset="177:187" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.3" text="vecuronium" type="Drug"><Normalization><mmtx cui="C0242531" phraseText="recovery from the neuromuscular blocking agent vecuronium," preferredWord="Vecuronium" semType="strd, phsu"/><RxNorm RxCui="71535"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.1"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.57.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="7" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67" lineNumber="64" text="Clinically significant interactions have been reported with inhibitors of CYP3A4 (e.g., erythromycin, ritonavir) causing elevation of plasma levels of verapamil while inducers of CYP3A4 (e.g., rifampin) have caused a lowering of plasma levels of verapamil." type="regular"><entity charOffset="60:80" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.0" text="inhibitors of CYP3A4" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="88:100" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.1" text="erythromycin" type="Drug"><Normalization><mmtx cui="C0014806" phraseText="erythromycin," preferredWord="Erythromycin" semType="orch, antb"/><RxNorm RxCui="4053"/></Normalization></entity><entity charOffset="102:111" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.2" text="ritonavir" type="Drug"><Normalization><mmtx cui="C0292818" phraseText="ritonavir" preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="121:147" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.5" text="elevation of plasma levels" type="Increase_Interaction"/><entity charOffset="151:160" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.7" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="causing elevation of plasma levels of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="causing elevation of plasma levels of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="167:185" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.8" text="inducers of CYP3A4" type="Drug_Class"><Normalization><RxNorm RxCui="993159"/></Normalization></entity><entity charOffset="193:201" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.9" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="217:242" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.11" text="lowering of plasma levels" type="Decrease_Interaction"/><entity charOffset="246:255" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.13" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="a lowering of plasma levels of verapamil." preferredWord="Verapamil" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="a lowering of plasma levels of verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugClassMembership drug="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.1" drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.0"/><drugClassMembership drug="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.2" drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.0"/><drugClassMembership drug="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.9" drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.8"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.11"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.13"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.8"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.7" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.5" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.8" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.13" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.67.e.11" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69" lineNumber="68" text="The use of HMG-CoA reductase inhibitors that are CYP3A4 substrates in combination with verapamil has been associated with reports of myopathy/rhabdomyolysis." type="regular"><entity charOffset="11:66" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.0" text="HMG-CoA reductase inhibitors that are CYP3A4 substrates" type="Drug_Class"><Normalization><mmtx cui="C0360714" phraseText="The use of HMG-CoA reductase inhibitors" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="27274"/></Normalization></entity><entity charOffset="87:96" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="133:141" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.2" text="myopathy" type="Specific_Interaction"><Normalization><mmtx cui="C0026848" phraseText="associated with reports of myopathy/rhabdomyolysis." preferredWord="Myopathy" semType="dsyn"/></Normalization></entity><entity charOffset="142:156" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.4" text="rhabdomyolysis" type="Specific_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.2"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.4"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.69.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70" lineNumber="70" text="Co-administration of multiple doses of 10 mg of verapamil with 80 mg simvastatin resulted in exposure to simvastatin 2.5-fold that following simvastatin alone. " type="regular"><entity charOffset="48:57" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Co-administration of multiple doses of 10 mg of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="93:101|121:125" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.1" text="exposure fold" type="Increase_Interaction"/><entity charOffset="105:116" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.3" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="to simvastatin 2.5-fold" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.70.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71" lineNumber="70" text="Limit the dose of simvastatin in patients on verapamil to 10 mg daily. " type="regular"><entity charOffset="0:14" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.0" text="Limit the dose" type="Caution_Interaction"/><entity charOffset="18:29" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the dose of simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="45:54" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="on verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.72" lineNumber="70" text="Limit the daily dose of lovastatin to 40 mg. " type="irregular"><entity charOffset="0:9|16:20" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.72.e.0" text="Limit the dose" type="Caution_Interaction"/><entity charOffset="24:34" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.72.e.2" text="lovastatin" type="Drug"><Normalization><mmtx cui="C0024027" phraseText="the daily dose of lovastatin" preferredWord="Lovastatin" semType="phsu, orch"/><RxNorm RxCui="6472"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.72.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.72.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71" text="Limit the dose of simvastatin in patients on verapamil to 10 mg daily. "><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.71.e.3"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.72.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.72.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73" lineNumber="70" text="Lower starting and maintenance doses of other CYP3A4 substrates (e.g., atorvastatin) may be required as verapamil may increase the plasma concentration of these drugs." type="regular"><anaphoraRelation><anaphoraEntity charOffset="155:166" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.4" text="these drugs" type="Expression"/><antecedentEntity charOffset="46-63" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.0" text="CYP3A4 substrates" type="Drug_Class"/></anaphoraRelation><entity charOffset="46:63" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.0" text="CYP3A4 substrates" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><entity charOffset="71:83" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.1" text="atorvastatin" type="Drug"><Normalization><mmtx cui="C0286651" phraseText="atorvastatin" preferredWord="atorvastatin" semType="phsu, orch"/><RxNorm RxCui="83367"/></Normalization></entity><entity charOffset="104:113" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="required as verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="118:151" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.6" text="increase the plasma concentration" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.1" drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.0"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.4" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.73.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75" lineNumber="74" text="In a few reported cases, co-administration of verapamil with aspirin has led to increased bleeding times greater than observed with aspirin alone." type="regular"><entity charOffset="46:55" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="co-administration of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="5:23" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.1" text="few reported cases" type="SPAN"/><entity charOffset="61:68" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="with aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="80:104" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.3" text="increased bleeding times" type="Specific_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.3"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.1" ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.2" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.75.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77" lineNumber="78" text="Grapefruit juice may increase plasma levels of verapamil." type="regular"><entity charOffset="0:16" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.0" text="Grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="Grapefruit juice" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="47:56" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="plasma levels of verapamil." preferredWord="Verapamil" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="plasma levels of verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="21:43" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.2" text="increase plasma levels" type="Increase_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.2"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.77.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79" lineNumber="82" text="Verapamil may increase blood alcohol concentrations and prolong its effects." type="regular"><anaphoraRelation><anaphoraEntity charOffset="64:67" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.4" text="its" type="Expression"/><antecedentEntity charOffset="29-36" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.1" text="alcohol" type="Substance"/></anaphoraRelation><entity charOffset="0:9" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.0" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="29:36" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.1" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="blood alcohol concentrations" preferredWord="Alcohols" semType="phsu, orch"/><mmtx cui="C0001975" phraseText="blood alcohol concentrations" preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="14:28|37:51" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.2" text="increase blood concentrations" type="Increase_Interaction"/><entity charOffset="56:63|68:75" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.6" text="prolong effects" type="Increase_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.6"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.4" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.79.e.6" type="Increase_Interaction"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.81" text="Controlled studies in small numbers of patients suggest that the concomitant use of CALAN and oral beta-adrenergic blocking agents may be beneficial in certain patients with chronic stable angina or hypertension, but available information is not sufficient to predict with confidence the effects of concurrent treatment in patients with left ventricular dysfunction or cardiac conduction abnormalities. " type="negative"><entity charOffset="99:130" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.81.e.0" text="beta-adrenergic blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="oral beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="84:89" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.81.e.1" text="calan" type="Biomedical_Entity"><Normalization><mmtx cui="C0700935" phraseText="the concomitant use of CALAN" preferredWord="Calan" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.81.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.81.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82" lineNumber="86" text="Concomitant therapy with beta-adrenergic blockers and verapamil may result in additive negative effects on heart rate, atrioventricular conduction and/or cardiac contractility." type="regular"><entity charOffset="25:49" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.0" text="beta-adrenergic blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="Concomitant therapy with beta-adrenergic blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="54:63" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="78:117" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.2" text="additive negative effects on heart rate" type="Specific_Interaction"/><entity charOffset="78:106|119:146" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.4" text="additive negative effects on atrioventricular conduction" type="Specific_Interaction"/><entity charOffset="78:106|154:175" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.6" text="additive negative effects on cardiac contractility" type="Specific_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.2"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.4"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.ddi.3"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.6"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.82.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85" lineNumber="88" text="The addition of verapamil to high-dose beta-blockers induced modest negative inotropic and chronotropic effects that were not severe enough to limit short-term (48 hours) combination therapy in this study. " type="regular"><entity charOffset="68:86|104:111" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.0" text="negative inotropic effects" type="Specific_Interaction"/><entity charOffset="68:76|91:111" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.2" text="negative chronotropic effects" type="Specific_Interaction"/><entity charOffset="16:25" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="The addition of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="39:52" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.5" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="to high-dose beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.4" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.5" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.85.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.86" text="These modest cardiodepressant effects persisted for greater than 6 but less than 30 hours after abrupt withdrawal of beta-blockers and were closely related to plasma levels of propranolol. " type="negative"><entity charOffset="176:187" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.86.e.0" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="related to plasma levels of propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="117:130" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.86.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="of beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.86.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.86.e.0"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.87" text="The primary verapamil/beta-blocker interaction in this study appeared to be hemodynamic rather than electrophysiologic." type="negative"><entity charOffset="12:21" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.87.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="The primary verapamil/beta-blocker interaction in this study" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="22:34" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.87.e.1" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="The primary verapamil/beta-blocker interaction in this study" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.87.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.87.e.1"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88" text="In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); " type="negative"><entity charOffset="210:221" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.0" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="moderate doses of propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="18:27" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.0"/></sentence><sentence biomedicalEntities="0" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89" lineNumber="90" text="in some patients, however, combined therapy did produce such effects. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88" Text="In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); "/><anaphoraEntity charOffset="56:68" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89.e.2" text="such effects" type="Expression"/><antecedentEntity charOffset="65:121" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.2" text="negative inotropic, chronotropic, or dromotropic effects" type="SPAN"/></anaphoraRelation><entity charOffset="56:68" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89.e.0" text="such effects" type="Specific_Interaction"/><entity charOffset="3:16" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89.e.3" text="some patients" type="SPAN"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89.e.0"><relations><relation type="hasEvidence"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88" text="In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); "><entity charOffset="18:27" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88" text="In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); "><entity charOffset="210:221" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.1" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="moderate doses of propranolol" preferredWord="Propranolol" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="0" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.90" lineNumber="90" text="Therefore, if combined therapy is used, close surveillance of clinical status should be carried out. " type="irregular"><entity charOffset="46:58" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.90.e.0" text="surveillance" type="Caution_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.90.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.90.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88" text="In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); "><entity charOffset="18:27" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89" text="in some patients, however, combined therapy did produce such effects. "/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88" text="In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); "><entity charOffset="210:221" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.1" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="moderate doses of propranolol" preferredWord="Propranolol" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89" text="in some patients, however, combined therapy did produce such effects. "/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="0" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.91" lineNumber="90" text="Combined therapy should usually be avoided in patients with atrioventricular conduction abnormalities and those with depressed left ventricular function." type="irregular"><entity charOffset="35:42" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.91.e.0" text="avoided" type="Caution_Interaction"/><entity charOffset="60:101" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.91.e.2" text="atrioventricular conduction abnormalities" type="SPAN"/><entity charOffset="117:152" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.91.e.3" text="depressed left ventricular function" type="SPAN"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.91.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.91.e.0"><relations><relation type="hasContext"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.91.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88" text="In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); "><entity charOffset="18:27" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89" text="in some patients, however, combined therapy did produce such effects. "/><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.90" text="Therefore, if combined therapy is used, close surveillance of clinical status should be carried out. "/></relation><relation type="hasContext"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.91.e.3"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88" text="In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); "><entity charOffset="210:221" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.88.e.1" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="moderate doses of propranolol" preferredWord="Propranolol" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.89" text="in some patients, however, combined therapy did produce such effects. "/><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.90" text="Therefore, if combined therapy is used, close surveillance of clinical status should be carried out. "/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92" lineNumber="92" text="Asymptomatic bradycardia (36 beats/min) with a wandering atrial pacemaker has been observed in a patient receiving concomitant timolol (a beta-adrenergic blocker) eyedrops and oral verapamil." type="regular"><entity charOffset="0:24|40:73" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.0" text="Asymptomatic bradycardia with a wandering atrial pacemaker" type="Specific_Interaction"/><entity charOffset="95:104" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.2" text="a patient" type="SPAN"/><entity charOffset="138:161" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.3" text="beta-adrenergic blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="(a beta-adrenergic blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="(a beta-adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="127:134|163:171" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.4" text="timolol eyedrops" type="Drug"><Normalization><mmtx cui="C0040233" phraseText="concomitant timolol" preferredWord="Timolol" semType="phsu, orch"/><mmtx cui="C0001645" phraseText="(a beta-adrenergic blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="(a beta-adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="42933"/></Normalization></entity><entity charOffset="176:190" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.6" text="oral verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="oral verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.4" drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.3"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.0"><relations><relation type="hasContext"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.6"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.2" ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.4" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.6" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.92.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93" lineNumber="94" text="A decrease in metoprolol and propranolol clearance has been observed when either drug is administered concomitantly with verapamil. " type="regular"><entity charOffset="2:13|41:50" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.0" text="decrease in clearance" type="Increase_Interaction"/><entity charOffset="14:24" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.2" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="A decrease in metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="29:40" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.3" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="propranolol clearance" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="121:130" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concomitantly with verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.0"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.4" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.4" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.0" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.93.e.3"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.94" text="A variable effect has been seen when verapamil and atenolol were given together." type="negative"><entity charOffset="37:46" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.94.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="51:59" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.94.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.94.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.94.e.1"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.96" text="Clinical use of verapamil in digitalized patients has shown the combination to be well tolerated if digoxin doses are properly adjusted. " type="negative"><entity charOffset="16:25" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.96.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="Clinical use of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="100:107" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.96.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin doses" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.96.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.96.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97" lineNumber="98" text="However, chronic verapamil treatment can increase serum digoxin levels by 50% to 75% during the first week of therapy, and this can result in digitalis toxicity. " type="regular"><entity charOffset="41:55|64:70" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.0" text="increase serum levels" type="Increase_Interaction"/><entity charOffset="17:26" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="chronic verapamil treatment" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="56:63" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.3" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="serum digoxin levels by 50%" preferredWord="Digoxin" semType="strd, phsu, carb"/><mmtx cui="C0012265" phraseText="serum digoxin levels by 50%" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="152:160" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.4" text="toxicity" type="Increase_Interaction"/><entity charOffset="142:151" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.6" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="result in digitalis toxicity." preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.4"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.6" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.97.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98" lineNumber="98" text="In patients with hepatic cirrhosis, the influence of verapamil on digoxin kinetics is magnified. " type="regular"><entity charOffset="74:95" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.0" text="kinetics is magnified" type="Specific_Interaction"/><entity charOffset="17:34" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.2" text="hepatic cirrhosis" type="SPAN"><Normalization><mmtx cui="C0023890" phraseText="with hepatic cirrhosis," preferredWord="Liver Cirrhosis" semType="dsyn"/></Normalization></entity><entity charOffset="53:62" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="the influence of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="66:73" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.4" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="on digoxin kinetics" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.2" ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.4" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.98.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99" lineNumber="98" text="Verapamil may reduce total body clearance and extrarenal clearance of digitoxin by 27% and 29%, respectively. " type="regular"><entity charOffset="14:41" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.0" text="reduce total body clearance" type="Increase_Interaction"/><entity charOffset="14:20|46:66" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.2" text="reduce extrarenal clearance" type="Increase_Interaction"/><entity charOffset="70:79" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.4" text="digitoxin" type="Drug"><Normalization><mmtx cui="C0012258" phraseText="extrarenal clearance of digitoxin" preferredWord="Digitoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3403"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.5" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.0"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.2"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.5" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.4" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.99.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104" lineNumber="102" text="Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta-blockers) will usually have an additive effect on lowering blood pressure. " type="regular"><entity charOffset="0:9" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.0" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="42:70" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.1" text="oral antihypertensive agents" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="concomitantly with oral antihypertensive agents" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="78:90" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.2" text="vasodilators" type="Drug_Class"><Normalization><mmtx cui="C0042402" phraseText="vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="92:132" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.3" text="angiotensin-converting enzyme inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="134:143" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.4" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="145:158" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.5" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="181:223" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.6" text="additive effect on lowering blood pressure" type="Specific_Interaction"/><classClassMembership drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.2"/><classClassMembership drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.3"/><classClassMembership drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.4"/><classClassMembership drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.5"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.105" lineNumber="102" text="Patients receiving these combinations should be appropriately monitored. " type="irregular"><entity charOffset="62:71" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.105.e.0" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.105.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.105.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104" text="Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta-blockers) will usually have an additive effect on lowering blood pressure. "><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104" text="Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta-blockers) will usually have an additive effect on lowering blood pressure. "><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.104.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106" lineNumber="102" text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in a reduction in blood pressure that is excessive in some patients. " type="regular"><entity charOffset="19:66" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.0" text="agents that attenuate alpha-adrenergic function" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="Concomitant use of agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="72:81" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="alpha-adrenergic function with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="98:125" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.2" text="reduction in blood pressure" type="Specific_Interaction"/><entity charOffset="147:160" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.4" text="some patients" type="SPAN"/><entity charOffset="98:125" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.5" text="reduction in blood pressure" type="SPAN"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.0"/></relation><relation type="hasEvidence"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.1" evidence="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.4" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107" lineNumber="102" text="Such an effect was observed in one study following the concomitant administration of verapamil and prazosin." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106" Text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in a reduction in blood pressure that is excessive in some patients. "/><anaphoraEntity charOffset="0:14" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.4" text="Such an effect" type="Expression"/><antecedentEntity charOffset="98:125" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.2" text="reduction in blood pressure" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106" Text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in a reduction in blood pressure that is excessive in some patients. "/><anaphoraEntity charOffset="0:14" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.4" text="Such an effect" type="Expression"/><antecedentEntity charOffset="98:125" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.106.e.5" text="reduction in blood pressure" type="SPAN"/></anaphoraRelation><entity charOffset="0:14" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.0" text="Such an effect" type="Specific_Interaction"/><entity charOffset="85:94" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="the concomitant administration of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="99:107" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.3" text="prazosin" type="Drug"><Normalization><mmtx cui="C0032912" phraseText="prazosin." preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.0"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.107.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110" lineNumber="108" text="Until data on possible interactions between verapamil and disopyramide are obtained, disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration." type="regular"><entity charOffset="105:124" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.0" text="not be administered" type="Caution_Interaction"/><entity charOffset="85:97" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.2" text="disopyramide" type="Drug"><Normalization><mmtx cui="C0012702" phraseText="disopyramide" preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="166:175" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="24 hours after verapamil administration." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.110.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112" lineNumber="112" text="A study in healthy volunteers showed that the concomitant administration of flecainide and verapamil may have additive effects on myocardial contractility, AV conduction, and repolarization. " type="regular"><entity charOffset="76:86" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.0" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="the concomitant administration of flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="91:100" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="110:154" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.2" text="additive effects on myocardial contractility" type="Specific_Interaction"/><entity charOffset="110:129|156:169" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.4" text="additive effects on AV conduction" type="Specific_Interaction"/><entity charOffset="110:129|175:189" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.6" text="additive effects on repolarization" type="Specific_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.ddi.3"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.112.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113" lineNumber="112" text="Concomitant therapy with flecainide and verapamil may result in additive negative inotropic effect and prolongation of atrioventricular conduction." type="regular"><entity charOffset="25:35" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.0" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="Concomitant therapy with flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="40:49" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="64:98" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.2" text="additive negative inotropic effect" type="Specific_Interaction"/><entity charOffset="103:146" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.4" text="prolongation of atrioventricular conduction" type="Specific_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.2"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.4"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.113.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115" lineNumber="116" text="In a small number of patients with hypertrophic cardiomyopathy (IHSS), concomitant use of verapamil and quinidine resulted in significant hypotension. " type="regular"><entity charOffset="90:99" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concomitant use of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="35:62" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.1" text="hypertrophic cardiomyopathy" type="SPAN"><Normalization><mmtx cui="C0007194" phraseText="with hypertrophic cardiomyopathy" preferredWord="Hypertrophic Cardiomyopathy" semType="dsyn"/></Normalization></entity><entity charOffset="104:113" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="5:29" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.3" text="small number of patients" type="SPAN"/><entity charOffset="138:149" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.4" text="hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.4"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.1"/></relation><relation type="hasEvidence"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.1" ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.2" evidence="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.115.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116" lineNumber="116" text="Until further data are obtained, combined therapy of verapamil and quinidine in patients with hypertrophic cardiomyopathy should probably be avoided." type="regular"><entity charOffset="53:62" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="combined therapy of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="67:76" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.1" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine in patients" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="94:121" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.2" text="hypertrophic cardiomyopathy" type="SPAN"><Normalization><mmtx cui="C0007194" phraseText="with hypertrophic cardiomyopathy" preferredWord="Hypertrophic Cardiomyopathy" semType="dsyn"/></Normalization></entity><entity charOffset="141:148" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.3" text="avoided" type="Caution_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.3"><relations><relation type="hasContext"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.2" ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.116.e.3" type="Caution_Interaction"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.117" text="The electrophysiologic effects of quinidine and verapamil on AV conduction were studied in 8 patients. " type="negative"><entity charOffset="48:57" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.117.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil on AV conduction" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="34:43" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.117.e.1" text="quinidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0034414" phraseText="The electrophysiologic effects of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.117.e.1" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.117.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118" lineNumber="118" text="Verapamil significantly counteracted the effects of quinidine on AV conduction. " type="regular"><entity charOffset="0:9" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.0" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil significantly" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="52:61" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.1" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="the effects of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="24:48|62:78" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.2" text="counteracted the effects on AV conduction" type="Specific_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.2"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.118.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119" lineNumber="118" text="There has been a report of increased quinidine levels during verapamil therapy." type="regular"><entity charOffset="27:36|47:53" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.0" text="increased levels" type="Increase_Interaction"/><entity charOffset="37:46" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="a report of increased quinidine levels" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="61:70" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="during verapamil therapy." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="15:23" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.4" text="a report" type="SPAN"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.0"><relations><relation type="hasEvidence"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.3" evidence="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.4" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.119.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.125" text="The interaction between cimetidine and chronically administered verapamil has not been studied. " type="negative"><entity charOffset="24:34" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.125.e.0" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="The interaction between cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="64:73" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.125.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="chronically administered verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.125.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.125.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129" lineNumber="132" text="Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy; " type="regular"><entity charOffset="101:110" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="reported during concomitant verapamil-lithium therapy" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="111:118" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.1" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="reported during concomitant verapamil-lithium therapy" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="40:47" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Increased sensitivity to the effects of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="49:62" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.3" text="neurotoxicity" type="Specific_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.3"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.0" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.131" lineNumber="132" text="Patients receiving both drugs must be monitored carefully." type="irregular"><entity charOffset="38:47" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.131.e.0" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.131.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.131.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129" text="Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy; "><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.1"/></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.130" text="lithium levels have been observed sometimes to increase, sometimes to decrease, and sometimes to be unchanged. "/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129" text="Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy; "><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.129.e.0"/></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.130" text="lithium levels have been observed sometimes to increase, sometimes to decrease, and sometimes to be unchanged. "/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133" lineNumber="136" text="Verapamil therapy may increase carbamazepine concentrations during combined therapy. " type="regular"><entity charOffset="22:30|45:59" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.0" text="increase concentrations" type="Increase_Interaction"/><entity charOffset="31:44" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.2" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine concentrations during combined therapy." preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.3" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil therapy" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.0"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.3" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.2" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.133.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136" lineNumber="140" text="Therapy with rifampin may markedly reduce oral verapamil bioavailability." type="regular"><entity charOffset="13:21" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.0" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="Therapy with rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="42:56" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.1" text="oral verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="oral verapamil bioavailability." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="35:41|57:72" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.2" text="reduce bioavailability" type="Decrease_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.2"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.136.e.2" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138" lineNumber="144" text="Phenobarbital therapy may increase verapamil clearance." type="regular"><entity charOffset="0:13" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.0" text="Phenobarbital" type="Drug"><Normalization><mmtx cui="C0031412" phraseText="Phenobarbital therapy" preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><entity charOffset="35:44" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil clearance." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="26:34|45:54" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.2" text="increase clearance" type="Decrease_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.2"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.138.e.2" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140" lineNumber="148" text="Verapamil therapy may increase serum levels of cyclosporine." type="regular"><entity charOffset="0:9" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.0" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil therapy" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="47:59" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.1" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="serum levels of cyclosporine." preferredWord="Cyclosporine" semType="phsu, aapp"/><mmtx cui="C0010592" phraseText="serum levels of cyclosporine." preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="22:43" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.2" text="increase serum levels" type="Increase_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.140.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142" lineNumber="152" text="Verapamil may inhibit the clearance and increase the plasma levels of theophylline." type="regular"><entity charOffset="0:9" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.0" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="70:82" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.1" text="theophylline" type="Drug"><Normalization><mmtx cui="C0039771" phraseText="the plasma levels of theophylline." preferredWord="Theophylline" semType="bacs, phsu, orch"/><mmtx cui="C0039771" phraseText="the plasma levels of theophylline." preferredWord="Theophylline" semType="bacs, phsu, orch"/><RxNorm RxCui="10438"/></Normalization></entity><entity charOffset="14:35" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.2" text="inhibit the clearance" type="Increase_Interaction"><Normalization><mmtx cui="C0018790" phraseText="inhibit" preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="40:66" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.4" text="increase the plasma levels" type="Increase_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.142.e.2" type="Increase_Interaction"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.144" text="Animal experiments have shown that inhalation anesthetics depress cardiovascular activity by decreasing the inward movement of calcium ions. " type="negative"><entity charOffset="35:57" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.144.e.0" text="inhalation anesthetics" type="Biomedical_Entity"><Normalization><mmtx cui="C0242903" phraseText="that inhalation anesthetics" preferredWord="Anesthetics, Inhalation" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="127:139" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.144.e.1" text="calcium ions" type="Biomedical_Entity"><Normalization><mmtx cui="C0596235" phraseText="the inward movement of calcium ions." preferredWord="Calcium ion" semType="phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.144.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.144.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145" lineNumber="156" text="When used concomitantly, inhalation anesthetics and calcium antagonists, such as verapamil, should each be titrated carefully to avoid excessive cardiovascular depression." type="regular"><entity charOffset="25:47" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.0" text="inhalation anesthetics" type="Drug_Class"><Normalization><mmtx cui="C0242903" phraseText="inhalation anesthetics" preferredWord="Anesthetics, Inhalation" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="52:71" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.1" text="calcium antagonists" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium antagonists," preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="81:90" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="such as verapamil," preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="99:125" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.4" text="each be titrated carefully" type="Caution_Interaction"/><drugClassMembership drug="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.2" drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.1"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.4"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.145.e.4" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147" lineNumber="160" text="Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). " type="regular"><entity charOffset="60:83" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.0" text="potentiate the activity" type="Increase_Interaction"/><entity charOffset="46:55" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="that verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="18:32" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.3" text="animal studies" type="SPAN"/><entity charOffset="87:116|118:129" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.4" text="neuromuscular blocking agents curare-like" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="the activity of neuromuscular blocking agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0010463" phraseText="(curare-" preferredWord="Curare" semType="phsu, orch, hops"/><RxNorm RxCui="1036249"/></Normalization></entity><entity charOffset="87:116|134:146" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.5" text="neuromuscular blocking agents depolarizing" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="the activity of neuromuscular blocking agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0010463" phraseText="(curare-" preferredWord="Curare" semType="phsu, orch, hops"/><RxNorm RxCui="1036249"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.0"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.4"/></relation><relation type="hasEvidence"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.4" evidence="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.5" evidence="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.147.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148" lineNumber="160" text="It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly." type="regular"><entity charOffset="23:40" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.0" text="decrease the dose" type="Caution_Interaction"/><entity charOffset="44:53" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="the dose of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="77:105" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.3" text="neuromuscular blocking agent" type="Drug_Class"><Normalization><mmtx cui="C0027866" phraseText="the dose of the neuromuscular blocking agent" preferredWord="Neuromuscular Blocking Agents" semType="phsu"/><RxNorm RxCui="1036249"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.0"><relations><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150" lineNumber="164" text="Hypotension and bradyarrhythmias have been observed in patients receiving concurrent telithromycin, an antibiotic in the ketolide class." type="irregular"><entity charOffset="85:98" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.0" text="telithromycin" type="Drug"><Normalization><mmtx cui="C0907410" phraseText="concurrent telithromycin," preferredWord="telithromycin" semType="orch, antb"/><RxNorm RxCui="274786"/></Normalization></entity><entity charOffset="103:135" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.1" text="antibiotic in the ketolide class" type="Drug_Class"><Normalization><mmtx cui="C0003232" phraseText="an antibiotic in the ketolide class." preferredWord="Antibiotics" semType="antb"/><mmtx cui="C1449860" phraseText="an antibiotic in the ketolide class." preferredWord="Ketolides" semType="phsu, orch"/><RxNorm RxCui="901"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.3" text="Hypotension" type="Specific_Interaction"/><entity charOffset="16:32" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.5" text="bradyarrhythmias" type="Specific_Interaction"><Normalization><mmtx cui="C0079035" phraseText="bradyarrhythmias" preferredWord="Bradyarrhythmia (disorder)" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.0" drugClass="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.1"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148" text="It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly."><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.2"/></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.149" text="Telithromycin"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.ddi.2"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.5"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148" text="It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly."><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.148.e.2"/></ellipsisSentence><middleSentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.149" text="Telithromycin"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.150.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152" lineNumber="168" text="Sinus bradycardia resulting in hospitalization and pacemaker insertion has been reported in association with the use of clonidine concurrently with verapamil. " type="regular"><entity charOffset="0:17" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.0" text="Sinus bradycardia" type="Specific_Interaction"/><entity charOffset="120:129" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.2" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="of clonidine concurrently" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="148:157" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="with verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.2" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.3" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.152.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153" lineNumber="168" text="Monitor heart rate in patients receiving concomitant verapamil and clonidine." type="regular"><entity charOffset="53:62" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concomitant verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="67:76" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.1" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="clonidine." preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.2" text="Monitor" type="Caution_Interaction"/><drugInteraction id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.ddi.1"><interaction trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.1" trigger="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.153.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.173" text="The antihypertensive effects of CALAN are evident within the first week of therapy. " type="negative"><entity charOffset="4:20" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.173.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="The antihypertensive effects of CALAN" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="32:37" id="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.173.e.1" text="calan" type="Biomedical_Entity"><Normalization><mmtx cui="C0700935" phraseText="The antihypertensive effects of CALAN" preferredWord="Calan" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><pair ddi="false" e1="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.173.e.0" e2="Dailymed.55d5f933-42ff-4c80-a102-0ccb7f76b082.s.173.e.1"/></sentence><positiveExamples number="46"/><negativeExamples number="32"/></document>